S Korean drug firm SK Bioscience targets IPO in first half of 2021

S Korean drug firm SK Bioscience targets IPO in first half of 2021

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter